Media 2021

Media 2021

December

Placental cell therapy could deliver new treatment options for liver disease
Associate Professor Rebecca Lim, Mihiri Goonetilleke
Medical Express

Why Invion’s progress towards TNBC treatment can be a game changer
Kalkine Media

3D-bioprinted urogynaecological repair treatment
Dr Kallyanashis Paul, Professor Caroline Gargett, Dr Shayanti Mukherjee
Hospital and healthcare

Insights into Invion’s progress in PhotosoftTM technology for cancer treatment as it gears up for an exciting 2022
Kalkine media

Neural stem cells may hold key to combatting newborn brain injury
News Binding

Noxopharm In-Licenses Novel RNA Technology From Hudson Institute of Medical Research
Associate Professor Michael Gantier
MarketWatch
BusinessWire
Street Insider
Daily Herald Chicago
Biopharma Reporter

November

New hope in lung cancer war
Dr Daniel Gough
Herald Sun
Hobart Mercury
Weekend Gold Coast Bulletin
Medical Xpress
News Binding

How the resented AstraZeneca vaccine could save Australia
Professor Bryan Williams
Daily Mail

Neural stem cells may hold key to combatting newborn brain injury
Today UK News
California News Times

Melbourne scientists have found a way to lessen the side effects of covid-19 vaccines
Professor Michael Gantier
Radio | 3AW
Radio | 5AA
The Australian

Noxopharm (ASX:NOX) signs licensing agreement with Hudson Institute for RNA technology
Professor Michael Gantier
The Market Herald
Proactive Investors

New hope for sick newborns
Professor Suzanne Miller
TV | 9 News
TV | 7 News
Radio | 4BC
Herald Sun
Daily Telegraph
Adelaide Advertiser
Courier Mail

Flicking the inflammation off-switch
Associate Professor Claudia Nold, Professor Marcel Nold
UK Today News
Florida News Times
Medical Express
Pledge Times

October

Study shows Invion’s INV043 could regress triple negative breast cancer tumours
Small caps

Invion (ASX:IVX) sees complete regression of tumours in breast cancer trial
Dr Andrew Stephens
The Market Herald

Hudson CEO appointed to NHMRC Council
Professor Elizabeth Hartland
Hospital Healthcare
Eminetra

Rocks for ROC | a rare ovarian cancer
Radio | ABC Illawarra

Invion has productive quarter following $4.5m capital raise for next-gen photodynamic therapy to treat billion-dollar diseases
Small caps

Noxopharm well-funded to advance “rapidly expanding” clinical program
Proactive Investors

Invion, Dimerix, Orthocell: Promising ASX stocks to watch amid biotech boom
Kalkine Media

Hearts in the right place
Dr Andrew Stephens
CEO Sydney

September

Renowned Scientists Added To Scientific Advisory Group
Dr Minna-Liisa Änkö
Premier of VIC

Hearts in the Right Place: Thian Chew
Dr Andrew Stephens
CEO Magazine

How Do Bats Resist COVID? Insights Could Lead to New Treatments for Humans
Professor Marcel Nold, Associate Professor Claudia Nold
Herald Sun
UKTodayNews
SciTechDaily
California New Times
USA Newsguru
EurekAlert
LeakHerald
Fiercebiotech
Earth

A GP guide to primary aldosteronism
Dr Jun Yang
Australian Doctor Group

Research team lead by Dr Jim Vadolas develops viral gene therapy to treat beta thalassaemia
Dr Jim Vadolas, Dr Tiwa Nualkaew
Neos Kosmos

Invion advances ‘exciting’ photodynamic therapy to treat a range of cancers
Dr Andrew Stephens
Small Caps

Global female scholars award opens for 2022
Dr Shayanti Mukherjee
BiotechDispatch

Can Invion’s promising technology do more than just treat cancer patients?
Dr Andrew Stephens
Kalkline Media

Viruses and the COVID-19 pandemic
Professor Bryan Williams
Radio | 2NUR

August

Noxopharm Preclinical Data Further Supports Anti-Inflammatory Role of Idronoxil in the Treatment of COVID-19
Associate Professor Michael Gantier
Street Insider
Galv News
Yahoo Finance

Coffee sellers a sign of pandemic desperation | Covid-19 research
The Australian

Breathing support improves lung function in near-term newborns
Erin McGillick
Today UK News

Invion Group to expand its promising photodynamic therapy technology into new markets
Dr Andrew Stephens
Small Caps

Noxopharm’s Veyonda® may offer other therapeutic opportunities in chronic inflammatory and autoimmune diseases
Professor Michael Gantier
Proactive Investors
Yahoo Finance

July

Geelong MPs questioned on whether they will donate their minimum pay rise to charity
Herald Sun
Geelong Advertiser

Australian biotech submits for approval of world first microbial therapy
News for Business
Medianet
Pharmacy ITK

June

Maria Alexiadis OAM: Part-time scientist, part-time Kumite sensei
Maria Alexiadis
Greek Herald

New drugs may kill and limit reproduction of bowel cancer cells
Associate Professor Ron Firestein
TV | 9 News
Radio | 2GB
InSight+

Photodynamic therapy to reduce tumours
The Pulse

May

Moderna ‘toxic’ vaccine claim a potent dose of misinformation
Dr Bryan Williams
AAP

Monash team co-develop lung disease drug
Associate Professor Michelle Tate
Herald Sun
Geelong Advertiser
Adelaide Advertiser

For International HR day, we’re celebrating HR initiatives that help businesses thrive
Belinda Pelle – HR
HRM – Australian HR Institute News

What 2,000-year-old poo says about our gut bugs
Dr Sam Forster
ABC

Breakthrough discovery for women suffering after traumatic childbirths
Professor Caroline Gargett, Dr Shayanti Mukherjee
TV | 7NEWS
Radio | ABC, 5AA
Herald Sun
Courier Mail

Developing early detection test for Ovarian cancer
Dr Maree Bilandzic
TV | 7NEWS
TV | 10NEWS

Protecting premature babies | discussing an often fatal disease called necrotising enterocolitis (NEC)
Associate Professor Claudia Nold, Professor Marcel Nold
ABC Babytalk podcast

April

Noxopharm’s interim trial data indicates Veyonda® potentially prevents cytokine storm in patients with moderately severe COVID-19 
Associate professor Michael Gantier
Proactive
Biotech

March

Australian scientists new world-first sperm discovery
Dr Liza O’Donnell
TV | National Nine News
Radio | ABC Newcastle

Tackling Ovarian Cancer
Associate Professor Ron Firestein
Australian Jewish News

Victorian Women Leading COVID-19 Research Charge
Associate Professor Michelle Tate
Premier of Victoria

Walk For a Worthy Cause
Tegan White, Charmaine Rock, Beth Piscopo
Crandbourne News

February

Ovarian Cancer: Hope on the Horizon
Dr Maree Bilandzic
Tonic magazine

A head start on migraine treatment
The West Australian

January

Building A Case To Beat The World’s Deadliest Diseases | NCIR
Premier of Victoria

Hon Jaala Pulford visits Hudson Institute
Professor Elizabeth Hartland, Professor Paul Hertzog, Professor Marcel Nold, Associate Professor Claudia Nold
Mirage News

Noxopharm says study advancing after clinical review
BiotechDispatch